Structure of an HIF-1α-pVHL Complex: Hydroxyproline Recognition in Signaling
The DOI matches its Crossref record, with a small difference in title or year; 25 of the 25 references it cites were found in a registry or an index.
Abstract
The ubiquitination of the hypoxia-inducible factor (HIF) by the von Hippel–Lindau tumor suppressor (pVHL) plays a central role in the cellular response to changes in oxygen availability. pVHL binds to HIF only when a conserved proline in HIF is hydroxylated, a modification that is oxygen-dependent. The 1.85 angstrom structure of a 20-residue HIF-1α peptide–pVHL–ElonginB–ElonginC complex shows that HIF-1α binds to pVHL in an extended β strand–like conformation. The hydroxyproline inserts into a gap in the pVHL hydrophobic core, at a site that is a hotspot for tumorigenic mutations, with its 4-hydroxyl group recognized by buried serine and histidine residues. Although the β sheet–like interactions contribute to the stability of the complex, the hydroxyproline contacts are central to the strict specificity characteristic of signaling.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The subsequent discovery of a peptide from hypoxia-inducible factor 1 subunit-α (HIF1α) that bound the E3 ligase von Hippel–Lindau tumour suppressor (VHL)18,19 led to the design of cell-penetrating PROTACs that degraded a range of POIs.”
From PROTAC targeted protein degraders: the past is prologue (2022) · cites this paper as [19]
Citations
Cites
MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures
Kraulis, P. J. (1991) · Journal of Applied Crystallography · doi:10.1107/s0021889891004399 · Cited by 14,085
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
Self-citationA conserved family of prolyl-4-hydroxylases that modify HIF
Bruick, R. K., & McKnight, S. L. (2001) · Science · doi:10.1126/science.1066373 · Cited by 2,549
Huang, L. E., Gu, J., Schau, M., & Bunn, H. F. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.7987 · Cited by 2,113
Ohh, M., Park, C. W., Ivan, M., Hoffman, M. A., Kim, T.-Y., Huang, L. E., Pavletich, N., Chau, V., & Kaelin, W. G. (2000) · Nature Cell Biology · doi:10.1038/35017054 · Cited by 1,577
Self-citationSCF and Cullin/RING H2-Based Ubiquitin Ligases
Deshaies, R. J. (1999) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.15.1.435 · Cited by 1,242
Masson, N., Willam, C., Maxwell, P. H., Pugh, C. W., & Ratcliffe, P. J. (2001) · The EMBO Journal · doi:10.1093/emboj/20.18.5197 · Cited by 1,014
Structural Basis of Collagen Recognition by Integrin α2β1
Emsley, J., Knight, C. G., Farndale, R. W., Barnes, M. J., & Liddington, R. C. (2000) · Cell · doi:10.1016/s0092-8674(00)80622-4 · Cited by 1,005
Research works printed but not linked: 2
- A. Pause et al. Proc. Natl. Acad. Sci. U.S.A. 94 2156 (1997).
- We thank P. Jeffrey for help with data collection and processing C. E. Stebbins and the members of the Pavletich lab for helpful discussions C. Murray and M. Minto for administrative assistance J. Crawford for peptide synthesis and the staff of the Cornell High Energy Synchrotron Source for help with data collection. This work was supported by the NIH the Howard Hughes Medical Institute the Dewitt Wallace Foundation the Samuel and May Rudin Foundation and the Arthur and Rochelle Belfer Foundation. Coordinates have been deposited in the RCSB Protein Data Bank (accession code 1LM8). Supporting Online Material www.sciencemag.org/cgi/content/full/1073440/DC1 Materials and Methods SFigs. 1 to S4
Cited by
Items 401–500 of 865
Zhang, Z., Zhang, S., Chen, H., Mao, Y., Li, Z., Kong, C., Han, B., Zhang, J., Chen, Y., Xue, W., et al. (2020) · Cell Proliferation · doi:10.1111/cpr.12853 · Cited by 33
Aptamer‐PROTAC Conjugates (APCs) for Tumor‐Specific Targeting in Breast Cancer
He, S., Gao, F., Ma, J., Ma, H., Dong, G., & Sheng, C. (2021) · Angewandte Chemie · doi:10.1002/ange.202107347 · Cited by 33
Chen, J., Ji, P., Gnawali, G. R., Chang, M., Gao, F., Xu, H., & Wang, W. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.12.018 · Cited by 33
Role of HIF in fish inflammation
Shi, X., Gao, F., Zhao, X., Pei, C., Zhu, L., Zhang, J., Li, C., Li, L., & Kong, X. (2023) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2023.109222 · Cited by 33
Liu, N., WANG, Y., Zhou, Y., Pang, H., Zhou, J., QIAN, P., Liu, L., & Zhang, H. (2014) · Oncology Reports · doi:10.3892/or.2014.3495 · Cited by 33
Willam, C., Nicholls, L. G., Ratcliffe, P. J., Pugh, C. W., & Maxwell, P. H. (2004) · Advances in Enzyme Regulation · doi:10.1016/j.advenzreg.2003.11.017 · Cited by 33
He, P., Han, Q., Liu, J., Liu, D., Zhao, X., Hu, T., Jiang, L., Dan, H., Zeng, X. Y., Li, J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083441 · Cited by 32
A positive feedback regulatory loop involving the lncRNA PVT1 and HIF-1α in pancreatic cancer
Zhu, Y., Wu, F., Gui, W., Zhang, N., Matro, E., Zhu, L., Eserberg, D. T., & Lin, X. (2021) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjab042 · Cited by 32
Isoform-specific interactions of the von Hippel-Lindau tumor suppressor protein
Minervini, G., Mazzotta, G. M., Masiero, A., Sartori, E., Corrà, S., Potenza, E., Costa, R., & Tosatto, S. C. E. (2015) · Scientific Reports · doi:10.1038/srep12605 · Cited by 32
Hurst, J. H. (2016) · Journal of Clinical Investigation · doi:10.1172/jci90055 · Cited by 32
Solution Structure of a Ubiquitin-like Domain from Tubulin-binding Cofactor B
Lytle, B. L., Peterson, F. C., Qiu, S., Luo, M., Zhao, Q., Markley, J. L., & Volkman, B. F. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409422200 · Cited by 32
Strategy and Design of In Situ Activated Protein Hydrolysis Targeted Chimeras
Lv, M.-Y., Hou, D., Liu, S., Cheng, D., & Wang, H. (2024) · ACS Nano · doi:10.1021/acsnano.4c11903 · Cited by 31
Lin, J., Chen, Z., Zhang, D., Zhang, N., Chen, H., & Guo, D. (2025) · Macromolecular Rapid Communications · doi:10.1002/marc.202401051 · Cited by 31
Association of the Hypoxia Inducible Factor-1α Gene Polymorphisms with Gastric Cancer in Tibetans
Li, K., Zhang, Y., Dan, Z., Wang, Y., & Ren, Z. C. (2009) · Biochemical Genetics · doi:10.1007/s10528-009-9254-2 · Cited by 31
Minervini, G., Quaglia, F., Tabaro, F., & Tosatto, S. C. E. (2019) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1006478 · Cited by 31
Erber, L. N., Luo, A., & Chen, Y. (2019) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra119.001535 · Cited by 31
Wottawa, M., Leisering, P., von Ahlen, M., Schnelle, M., Vogel, S., Malz, C. R., Bordoli, M. R., Camenisch, G., Hesse, A., Napp, J., et al. (2012) · International Journal of Cancer · doi:10.1002/ijc.27982 · Cited by 31
Lim, S. H., Kim, C., Aref, A. R., Kamm, R. D., & Raghunath, M. (2013) · Integrative Biology · doi:10.1039/c3ib40082d · Cited by 31
Roey, K. V., & Davey, N. E. (2015) · Cell Communication and Signaling · doi:10.1186/s12964-015-0123-9 · Cited by 31
Wang, Y., Zhang, P., Zhou, D. L., & Sun, C. P. (2004) · Physical Review B · doi:10.1103/physrevb.70.224515 · Cited by 31
Glutathione-responsive PROTAC for targeted degradation of ERα in breast cancer cells
Zhou, Z., Fan, H., Yu, D., Shi, F., Li, Q., Zhang, Z., Wang, X., Zhang, X., Dong, C., Sun, H., et al. (2023) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2023.117526 · Cited by 30
Bioinformatics Approaches for Predicting Disordered Protein Motifs
Bhowmick, P., Guharoy, M., & Tompa, P. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-20164-1_9 · Cited by 30
Herbal nutraceuticals: safe and potent therapeutics to battle tumor hypoxia
Devarajan, N., Jayaraman, S., & Ganesan, S. K. (2019) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-019-03068-x · Cited by 30
CITED2 and the modulation of the hypoxic response in cancer
Fernandes, M. T., Calado, S. M., Mendes-Silva, L., & Bragança, J. (2020) · World Journal of Clinical Oncology · doi:10.5306/wjco.v11.i5.260 · Cited by 30
Protein degrons and degradation: Exploring substrate recognition and pathway selection in plants
Isono, E., Li, J., Pulido, P., Siao, W., Spoel, S. H., Wang, Z., Zhuang, X., & Trujillo, M. (2024) · The Plant Cell · doi:10.1093/plcell/koae141 · Cited by 30
USP9X destabilizes pVHL and promotes cell proliferation
Zhang, C., Peng, Z., Zhu, M., Wang, P., Du, X., Li, X., Liu, Y., Jin, Y., McNutt, M. A., & Yin, Y. (2016) · Oncotarget · doi:10.18632/oncotarget.11139 · Cited by 30
Genotype-phenotype correlations in Chinese von Hippel-Lindau disease patients
Peng, S., Shepard, M. J., Wang, J., Li, T., Ning, X., Cai, L., Zhuang, Z., & Gong, K. (2017) · Oncotarget · doi:10.18632/oncotarget.16594 · Cited by 30
SF-deferoxamine, a bone-seeking angiogenic drug, prevents bone loss in estrogen-deficient mice
Guo, C., Yang, K., Yan, Y., Yan, D., Cheng, Y., Yan, X., Qian, N., Zhou, Q., Chen, B., Jiang, M., et al. (2018) · Bone · doi:10.1016/j.bone.2018.10.025 · Cited by 30
Hypoxia switches TET1 from being tumor-suppressive to oncogenic
Yang, Q., Dang, H., Liu, J., Wang, X., Wang, J., Lan, X., Ji, M., Xing, M., & Hou, P. (2023) · Oncogene · doi:10.1038/s41388-023-02659-w · Cited by 29
PROTAC-Based Protein Degradation as a Promising Strategy for Targeted Therapy in Sarcomas
Mancarella, C., Morrione, A., & Scotlandi, K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242216346 · Cited by 29
A fluorescence polarization-based interaction assay for hypoxia-inducible factor prolyl hydroxylases
Cho, H.-J., Park, H., & Yang, E. G. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.09.041 · Cited by 29
Sumoylation of hypoxia inducible factor-1α and its significance in cancer
Li, J., Xu, Y., Jiao, H., Wang, W., Mei, Z., & Chen, G. (2014) · Science China Life Sciences · doi:10.1007/s11427-014-4685-3 · Cited by 29
Organization of cell–regulatory systems through modular–protein–interaction domains
Pawson, T. J. (2003) · Philosophical Transactions of the Royal Society A Mathematical Physical and Engineering Sciences · doi:10.1098/rsta.2003.1197 · Cited by 29
Fu, C., Tyagi, R., Chin, A. C., Rojas, T., Li, R.-J., Guha, P., Bernstein, I. A., Rao, F., Xu, R., Cha, J. Y., et al. (2018) · Circulation Research · doi:10.1161/circresaha.117.311983 · Cited by 28
NADH elevation during chronic hypoxia leads to VHL-mediated HIF-1α degradation via SIRT1 inhibition
Joo, H.-Y., Jung, J. K., Kim, M., Woo, S. R., Jeong, J. M., Park, E., Kim, Y., Park, J., Kim, J., Yun, M., et al. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-01130-3 · Cited by 28
A self-assembled affibody-PROTAC conjugate nanomedicine for targeted cancer therapy
Li, Q., Yang, X., Zhao, M., Xia, X., Gao, W., Huang, W., Xia, X., & Yan, D. (2024) · Nano Research · doi:10.1007/s12274-024-6974-x · Cited by 28
Jang, Y., Choi, J., Park, B., Park, J. Y., Lee, J.-H., Goo, J., Shin, D., Kim, S. H., Kim, Y., Song, H. K., et al. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.06.028 · Cited by 28
Tissue Nutrient Environments and Their Effect on Regulatory T Cell Biology
Blagih, J., Hennequart, M., & Zani, F. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.637960 · Cited by 28
Sweet and Blind Spots in E3 Ligase Ligand Space Revealed by a Thermophoresis-Based Assay
Maiwald, S. A., Heim, C., Alvarez, B. H., & Hartmann, M. D. (2020) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.0c00440 · Cited by 28
Adding structural information to the von Hippel–Lindau (VHL) tumor suppressor interaction network
Leonardi, E., Murgia, A., & Tosatto, S. C. E. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.10.070 · Cited by 28
Pan, M., Yang, C., Fu, Z., Yang, Y., Zhuo, Y., Hou, H., & Li, J. (2025) · Advanced Science · doi:10.1002/advs.202501384 · Cited by 27
Survival in patients with clear cell renal cell carcinoma is predicted by HIF-1α expression.
Minardi, D., Lucarini, G., Santoni, M., Mazzucchelli, R., Burattini, L., Conti, A., Principi, E., Bianconi, M., Scartozzi, M., Milanese, G., et al. (2015) · PubMed · Cited by 27
West, C. M. (2003) · Cellular and Molecular Life Sciences · doi:10.1007/s000180300018 · Cited by 27
Structure of the transcribing RNA polymerase II–Elongin complex
Chen, Y., Kokić, G., Dienemann, C., Dybkov, O., Urlaub, H., & Cramer, P. (2023) · Nature Structural & Molecular Biology · doi:10.1038/s41594-023-01138-w · Cited by 26
Lippl, K., Boleininger, A., McDonough, M. A., Abboud, M. I., Tarhonskaya, H., Chowdhury, R., Loenarz, C., & Schofield, C. J. (2018) · Hypoxia · doi:10.2147/hp.s174655 · Cited by 26
von Hippel-Lindau disease: recent advances and therapeutic perspectives
Richard, S. (2003) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.3.2.215 · Cited by 26
Ogura, M., Shibata, T., Yi, J., Liu, J., Qu, R., Harada, H., & Hiraoka, M. (2005) · Cancer Science · doi:10.1111/j.1349-7006.2005.00044.x · Cited by 26
Garg, N., Kumar, P., Gadhave, K., & Giri, R. (2019) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2019.05.006 · Cited by 25
Chen, J., Liu, F., Li, H., Archacki, S. R., Gao, M., Liu, Y., Liao, S., Huang, M. N., Wang, J., Yu, S., et al. (2015) · Cellular Signalling · doi:10.1016/j.cellsig.2015.08.011 · Cited by 25
TLX controls angiogenesis through interaction with the von Hippel-Lindau protein
Zeng, Z.-J., Johansson, E., Hayashi, A., Chavali, P. L., Akrap, N., Yoshida, T., Kohno, K., Izumi, H., & Funa, K. (2012) · Biology Open · doi:10.1242/bio.2012893 · Cited by 25
Chakraborty, A. A. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.03.012 · Cited by 25
Akiyama, H. (2004) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.03-0282 · Cited by 24
The Role of Hypoxia in Endometrial Cancer
Salinas-Vera, Y. M., Gallardo‐Rincón, D., Ruíz‐García, E., Silva-Cázares, M. B., de la Peña-Cruz, C. S., & López‐Camarillo, C. (2021) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201022666210224130022 · Cited by 24
pVHL-mediated SMAD3 degradation suppresses TGF-β signaling
Zhou, J., Dabiri, Y., Gama-Brambila, R. A., Ghafoory, S., Altinbay, M., Mehrabi, A., Golriz, M., Blagojevic, B., Reuter, S., Han, K., et al. (2021) · The Journal of Cell Biology · doi:10.1083/jcb.202012097 · Cited by 24
Leonardi, E., Martella, M., Tosatto, S. C. E., & Murgia, A. (2011) · Annals of Human Genetics · doi:10.1111/j.1469-1809.2011.00647.x · Cited by 24
Wang, G., Song, H., Liu, S., Li, C., Geng, Y., & Gu, Z. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s65353 · Cited by 24
DCNL1 Functions as a Substrate Sensor and Activator of Cullin 2-RING Ligase
Heir, P., Sufan, R. I., Greer, S. N., Poon, B., Lee, J. E., & Ohh, M. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.01342-12 · Cited by 24
Jiang, Y., Ni, S., Xiao, B., & Jia, L. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.07.019 · Cited by 23
Shan, C., Xia, Y., Wu, Z., & Zhao, J. (2023) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2023.09.002 · Cited by 23
Thioamide substitution to probe the hydroxyproline recognition of VHL ligands
Soares, P., Lucas, X., & Ciulli, A. (2018) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2018.03.034 · Cited by 23
Shmueli, M. D., Levy-Kanfo, L., Haj, E., Schoenfeld, A. R., Gazit, E., & Segal, D. (2018) · Oncogene · doi:10.1038/s41388-018-0491-x · Cited by 23
van der Wel, H., Johnson, J. M., Xu, Y., Karunaratne, C. V., Wilson, K. D., Vohra, Y., Boons, G., Taylor, C. M., Bendiak, B. K., & West, C. M. (2011) · Biochemistry · doi:10.1021/bi101977w · Cited by 23
Genetophysiology: Using Genetic Strategies to Explore Hypoxic Adaptation
Grocott, M. P. W., & Montgomery, H. (2008) · High Altitude Medicine & Biology · doi:10.1089/ham.2008.1012 · Cited by 23
Hypoxic State of Cells and Immunosenescence: A Focus on the Role of the HIF Signaling Pathway
Troise, D. E., Infante, B., Mercuri, S., Netti, G. S., Ranieri, E., Gesualdo, L., Stallone, G., & Pontrelli, P. (2023) · Biomedicines · doi:10.3390/biomedicines11082163 · Cited by 22
Okadaic acid promotes angiogenesis via activation of hypoxia-inducible factor-1
Kim, Y., Ahn, K.-H., Kim, S.-Y., & Jeong, J. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.10.034 · Cited by 22
Tarade, D., Lee, J. E., & Ohh, M. (2019) · Nature Communications · doi:10.1038/s41467-019-11149-1 · Cited by 22
Gualdoni, G. S., Ventureira, M. R., Coll, T. A., Palomino, W. A., Barbeito, C. G., & Cebral, E. (2020) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2020.10.015 · Cited by 22
Xue, X., Kang, J.-B., Yang, X., Li, N., Chang, L., Ji, J., Meng, X., Zhang, H., Zhong, Y., Yu, S., et al. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113871 · Cited by 22
Pheochromocytoma/Paraganglioma: Is This a Genetic Disorder?
Fishbein, L. M. (2019) · Current Cardiology Reports · doi:10.1007/s11886-019-1184-y · Cited by 22
Iguchi, M., Kakinuma, Y., Kurabayashi, A., Sato, T., Shuin, T., Hong, S., Schmidt, L. S., & Furihata, M. (2008) · Nephron Experimental Nephrology · doi:10.1159/000166994 · Cited by 22
Prolyl 4 Hydroxylase: A Critical Target in the Pathophysiology of Diseases
Kant, R., Bali, A., Singh, N., & Jaggi, A. S. (2013) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2013.17.2.111 · Cited by 22
Engineering quantum decoherence of charge qubit via a nanomechanical resonator
Wang, Y. D., Gao, Y. B., & Sun, C. P. (2004) · The European Physical Journal B · doi:10.1140/epjb/e2004-00280-0 · Cited by 22
Large scale genotype‐ and phenotype‐driven machine learning in Von Hippel‐Lindau disease
Chiorean, A., Farncombe, K. M., DeLong, S., Andric, V., Ansar, S., Chan, C. F., Clark, K., Danos, A. M., Gao, Y. K., Giles, R. H., et al. (2022) · Human Mutation · doi:10.1002/humu.24392 · Cited by 21
Vu, L. P., Diehl, C. J., Casement, R., Bond, A. G., Steinebach, C., Strašek, N., Bricelj, A., Perdih, A., Schnakenburg, G., Sosič, I., et al. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c00434 · Cited by 21
Testosterone therapy-induced erythrocytosis: can phlebotomy be justified?
Bond, P., Verdegaal, T. J., & Smit, D. L. (2024) · Endocrine Connections · doi:10.1530/ec-24-0283 · Cited by 21
Effects of point mutations in pVHL on the binding of HIF‐1α
Domene, C., & Illingworth, C. J. R. (2011) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.23230 · Cited by 21
Teng, M., Jiang, X., Zhang, Q., Zhang, J.-P., Zhang, D., Liang, G., & Huang, Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035017 · Cited by 21
Phospholipase D1 protein coordinates dynamic assembly of HIF-1α-PHD-VHL to regulate HIF-1α stability
Park, M. H., Choi, K., Jung, Y., & Min, D. S. (2014) · Oncotarget · doi:10.18632/oncotarget.2613 · Cited by 21
Recent advances in epigenetic proteolysis targeting chimeras (Epi-PROTACs)
Tomaselli, D., Mautone, N., Mai, A., & Rotili, D. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112750 · Cited by 21
Light-Activating PROTACs in Cancer: Chemical Design, Challenges, and Applications
Negi, A., Kesari, K. K., & Voisin‐Chiret, A. S. (2022) · Applied Sciences · doi:10.3390/app12199674 · Cited by 21
Li, Z., Su, K., Jiang, Z., Yu, Y.-C., You, Q., & Zhang, X. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00688 · Cited by 20
Lin, W., Li, Y., Yang, L., & Chen, T. (2020) · ACS Omega · doi:10.1021/acsomega.0c05221 · Cited by 20
Fiorillo, A., Morea, V., Colotti, G., & Ilari, A. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11121309 · Cited by 20
Ethyl pyruvate stabilizes hypoxia-inducible factor 1 alpha via stimulation of the TCA cycle
Kim, S.-Y., Choi, J., Park, C., & Jeong, J. (2010) · Cancer Letters · doi:10.1016/j.canlet.2010.03.006 · Cited by 20
Wang, D., Ruan, H., Hu, L. J., Lamborn, K. R., Kong, E. L., Rehemtulla, A., & Deen, D. F. (2005) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700748 · Cited by 20
Gadd, M. S., Bulatov, E., & Ciulli, A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0131218 · Cited by 20
Li, Y., Shi, X., Yang, L. M., Mou, Y., Li, Y., Dang, R., & Li, C.-Y. (2017) · Gene · doi:10.1016/j.gene.2017.08.006 · Cited by 20
Zhou, Y., Lin, L., Wang, Y., Jin, X., Zhao, X., Liu, D., Hu, T., Jiang, L., Dan, H., Zeng, X. Y., et al. (2014) · Cancer Cell International · doi:10.1186/1475-2867-14-37 · Cited by 20
Illingworth, C. J. R., Loenarz, C., Schofield, C. J., & Domene, C. (2010) · Biochemistry · doi:10.1021/bi100358t · Cited by 20
Lewis, M. D., & Roberts, B. J. (2003) · Oncogene · doi:10.1038/sj.onc.1207384 · Cited by 21
Pan, Y., Wang, Y., & Gou, S. (2025) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2025.108491 · Cited by 19
Xiao, Z., Gavriil, E.-S., Cao, F., Zhang, X., Li, S. X., Kotelnikov, S., Michalska, P., Marte, F., Huang, C., Lu, Y., et al. (2025) · Journal of the American Chemical Society · doi:10.1021/jacs.5c01420 · Cited by 19
Kristan, A., Debeljak, N., & Kunej, T. (2019) · European Journal Of Haematology · doi:10.1111/ejh.13304 · Cited by 19
Corner, T. P., Teo, R. Z. R., Wu, Y., Salah, E., Nakashima, Y., Fiorini, G., Tumber, A., Brasnett, A., Holt‐Martyn, J. P., Figg, W. D., et al. (2023) · Chemical Science · doi:10.1039/d3sc04253g · Cited by 19
Oxygen-sensing mechanisms in development and tissue repair
Jiang, Y., Duan, L., & Fong, G. (2021) · Development · doi:10.1242/dev.200030 · Cited by 20
Negi, A., Kesari, K. K., & Voisin‐Chiret, A. S. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14112523 · Cited by 19
Shmueli, M. D., Schnaider, L., Rosenblum, D., Herzog, G., Gazit, E., & Segal, D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066333 · Cited by 19
Genotype–phenotype analysis of von Hippel–Lindau syndrome in fifteen Indian families
Vikkath, N., Govindan, S., Nampoothiri, S., Radhakrishnan, N., Pillai, G. S., Nair, V., Pooleri, G. K., Mathew, G., Menon, K. N., Ariyannur, P. S., et al. (2015) · Familial Cancer · doi:10.1007/s10689-015-9806-z · Cited by 19
Wang, S., Zhao, R., Wang, S., Gui, Z., Hou, M., Yan, X., & Jiang, B. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c01071 · Cited by 19
Ishii, H., Shibuya, M., So, Y., Wong, J. K. Y., Ho, E. N. M., Kusano, K., Sone, Y., Kamiya, T., Wakuno, A., Ito, H., et al. (2022) · Drug Testing and Analysis · doi:10.1002/dta.3247 · Cited by 18
Metadata
- Authors
- Min, J.-H., Yang, H., Ivan, M., Gertler, F., Kaelin, W. G., & Pavletich, N. P.
- Affiliations
- Memorial Sloan Kettering Cancer Center (US)
- Dana-Farber Cancer Institute (US)
- Massachusetts Institute of Technology (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Pavletich, Nikola P.
- Venue
- Science
- Published
- 2002-06-07
- Volume
- 296
- Issue
- 5574
- Pages
- 1886-1889
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2596045242
- Cited by
- 765
- References
- 25
- Citations by year
- 2026: 25 · 2025: 32 · 2024: 37 · 2023: 44 · 2022: 33 · 2021: 32 · 2020: 39 · 2019: 27 · 2018: 24 · 2017: 26 · 2016: 27 · 2015: 30 · 2014: 28 · 2013: 28 · 2012: 24
- FWCI
- 18.93
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Structural Biology › Enzyme Structure and Function
- Keywords
- HIF-1α, VHL, hydroxylation, protein-protein complex structure, hypoxia signaling, tumor suppressor mutations, beta-strand conformation, oxygen sensing
- MeSH terms
- Elongin, Amino Acid Sequence, Animals, Binding Sites, Humans, Hydrogen Bonding, Hydroxylation, Hydroxyproline, Ligases, Models, Molecular, Molecular Sequence Data, Mutation, Protein Conformation, Transcription Factors, Signal Transduction, Protein Structure, Secondary, Protein Structure, Tertiary, Crystallography, X-Ray, Tumor Suppressor Proteins, Ubiquitin-Protein Ligases, Macromolecular Substances, Mice, Von Hippel-Lindau Tumor Suppressor Protein, Hypoxia-Inducible Factor 1, alpha Subunit, Hydrophobic and Hydrophilic Interactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.